Thomas Ulich

2015

In 2015, Thomas Ulich earned a total compensation of $1.2M as Chief Scientific Officer at InVivo Therapeutics Holdings, a 8% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$118,016
Option Awards$722,345
Salary$318,643
Other$68,505
Total$1,227,509

Ulich received $722.3K in option awards, accounting for 59% of the total pay in 2015.

Ulich also received $118K in non-equity incentive plan, $318.6K in salary and $68.5K in other compensation.

Rankings

In 2015, Thomas Ulich's compensation ranked 6,951st out of 13,638 executives tracked by ExecPay. In other words, Ulich earned more than 49.0% of executives.

ClassificationRankingPercentile
All
6,951
out of 13,638
49th
Division
Manufacturing
2,630
out of 5,190
49th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
335
out of 760
56th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
186
out of 466
60th
Industry
Surgical and Medical Instruments and Apparatus
100
out of 293
66th
Source: SEC filing on April 25, 2017.

Ulich's colleagues

We found five more compensation records of executives who worked with Thomas Ulich at InVivo Therapeutics Holdings in 2015.

2015

Lorianne Masuoka

InVivo Therapeutics Holdings

Chief Medical Officer

2015

Mark Perrin

InVivo Therapeutics Holdings

Chief Executive Officer

2015

Tamara Joseph

InVivo Therapeutics Holdings

General Counsel

2015

Christopher McNulty

InVivo Therapeutics Holdings

Chief Financial Officer

2015

Steven McAllister

InVivo Therapeutics Holdings

Chief Financial Officer

In-depth

You may also like